论文信息 - Updated results from MONALEESA-2, a phase 3 trial of first-line ribociclib + letrozole in hormone receptor-positive (HR+), HER2-negative (HER2–), advanced breast cancer (ABC). - 字舞流文

Updated results from MONALEESA-2, a phase 3 trial of first-line ribociclib + letrozole in hormone receptor-positive (HR+), HER2-negative (HER2–), advanced breast cancer (ABC).

E. Winer | G. Hortobagyi | K. Blackwell | S. Verma | M. Campone | D. Cameron | H. Burris | C. Arteaga | J. O’Shaughnessy | Y. Yap | W. Janni | P. Conte | S. Paluch-Shimon | G. Sonke | K. Petráková | C. Germa | S. Hirawat | H. Burris | S. Stemmer | F. Xuan | E. Winer | M. Miller | M. Miller